30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Hospitals, Surgeons Provide Insight into Purchasing Priorities

The OMTEC® 2018 opening Keynote Panel offered perspective on hospital actions and priorities while addressing critical industry topics including pressure from public and private payors, bundled payments, value analysis committees and outpatient surgeries.

FDA 510(k) Highlights: Five Companies Gain First Orthopaedic Clearances

To meet your need to know who’s new in the orthopaedic market, I sorted through the 21 companies receiving their first orthopaedic-related FDA 510(k) clearance through May of this year. To keep things simple, I then chose one company from each implantable market segment for a closer look. Here’s what I found.

Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers

Alongside their 1Q18 results, numerous players reaffirmed or updated their full-year revenue guidance. Globus Medical increased its numbers based on adoption of ExcelsiusGPS, K2M grew its range by $3MM following a distributor partnership and Orthofix upped guidance by about $9MM in acquisition-related contributions. After the quarter’s close, Wright Medical announced FDA premarket approval for AUGMENT injectable bone graft, and will update its full-year guidance in the 2Q18 call.

Micro C Imaging: Conversations with Chief Medical Executives

Startup company Micro C Imaging is entering the fluoroscopy space by developing a hand-held x-ray and digital imaging device no larger or heavier than a digital camera. 

Trauma Market Attracts New Players

Established orthopaedic players and startups alike seek to enter the trauma segment, and we think this dynamic will make trauma one of the more exciting markets to watch in coming years. Here's why.

Page Navigation